Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Superficial parotid lobe-sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Zhang HB, Lu X, Huang SM, Wang L, Zhao C, Xia WX, Li SW, Wang FL, Zhu YL, Guo X, Xiang YQ.

Curr Oncol. 2013 Dec;20(6):e577-84. doi: 10.3747/co.20.1485.

PMID:
24311959
[PubMed]
Free PMC Article
2.

A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma.

Chau RM, Leung SF, Kam MK, Cheung KY, Kwan WH, Yu KH, Chiu SK, Chan AT.

Clin Oncol (R Coll Radiol). 2008 Mar;20(2):134-41. Epub 2007 Nov 26.

PMID:
18031999
[PubMed - indexed for MEDLINE]
3.

Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.

Kam MK, Chau RM, Suen J, Choi PH, Teo PM.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):145-57.

PMID:
12694833
[PubMed - indexed for MEDLINE]
4.

Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.

Cheng JC, Chao KS, Low D.

Int J Cancer. 2001 Apr 20;96(2):126-31.

PMID:
11291096
[PubMed - indexed for MEDLINE]
6.

A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.

Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, Low DA.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):907-16.

PMID:
11240231
[PubMed - indexed for MEDLINE]
7.

Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma. Effect on parotid gland radiation doses.

Uzel EK, Karaçam S, Eliçin O, Uzel O.

Strahlenther Onkol. 2013 Jul;189(7):552-8. doi: 10.1007/s00066-013-0344-z. Epub 2013 Jun 9.

PMID:
23748231
[PubMed - indexed for MEDLINE]
8.

Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy.

Hsiung CY, Ting HM, Huang HY, Lee CH, Huang EY, Hsu HC.

Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):454-61. Epub 2006 Jul 12.

PMID:
16839707
[PubMed - indexed for MEDLINE]
9.

Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study.

White P, Chan KC, Cheng KW, Chan KY, Chau MC.

J Radiat Res. 2013 May;54(3):532-45. doi: 10.1093/jrr/rrs111. Epub 2012 Nov 27.

PMID:
23188186
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Superiority of intensity-modulated radiotherapy over three-dimensional conformal radiotherapy combined with brachytherapy in nasopharyngeal carcinoma: a planning study.

Taheri-Kadkhoda Z, Pettersson N, Björk-Eriksson T, Johansson KA.

Br J Radiol. 2008 May;81(965):397-405. doi: 10.1259/bjr/36110151. Epub 2008 Feb 4.

PMID:
18250121
[PubMed - indexed for MEDLINE]
11.

Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.

Sun Y, Yu XL, Luo W, Lee AW, Wee JT, Lee N, Zhou GQ, Tang LL, Tao CJ, Guo R, Mao YP, Zhang R, Guo Y, Ma J.

Radiother Oncol. 2014 Mar;110(3):390-7. doi: 10.1016/j.radonc.2013.10.035. Epub 2014 Apr 7.

PMID:
24721546
[PubMed - in process]
Free Article
12.

Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.

van de Water TA, Lomax AJ, Bijl HP, Schilstra C, Hug EB, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e313-9. doi: 10.1016/j.ijrobp.2011.05.005. Epub 2011 Jun 25.

PMID:
21708427
[PubMed - indexed for MEDLINE]
13.

Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.

Eisbruch A, Ship JA, Dawson LA, Kim HM, Bradford CR, Terrell JE, Chepeha DB, Teknos TN, Hogikyan ND, Anzai Y, Marsh LH, Ten Haken RK, Wolf GT.

World J Surg. 2003 Jul;27(7):832-7.

PMID:
14509515
[PubMed - indexed for MEDLINE]
14.

Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT.

Lu SH, Cheng JC, Kuo SH, Lee JJ, Chen LH, Wu JK, Chen YH, Chen WY, Wen SY, Chong FC, Wu CJ, Wang CW.

Radiother Oncol. 2012 Sep;104(3):324-30. doi: 10.1016/j.radonc.2011.11.017. Epub 2012 Jan 9.

PMID:
22236614
[PubMed - indexed for MEDLINE]
15.

A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning system.

Xia P, Lee N, Liu YM, Poon I, Weinberg V, Shin E, Quivey JM, Verhey LJ.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):886-96.

PMID:
15183492
[PubMed - indexed for MEDLINE]
16.

Is uniform target dose possible in IMRT plans in the head and neck?

Vineberg KA, Eisbruch A, Coselmon MM, McShan DL, Kessler ML, Fraass BA.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1159-72.

PMID:
11955726
[PubMed - indexed for MEDLINE]
17.

The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.

Wu Q, Manning M, Schmidt-Ullrich R, Mohan R.

Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):195-205.

PMID:
10656393
[PubMed - indexed for MEDLINE]
18.

Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.

Münter MW, Karger CP, Hoffner SG, Hof H, Thilmann C, Rudat V, Nill S, Wannenmacher M, Debus J.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):175-84.

PMID:
14697436
[PubMed - indexed for MEDLINE]
19.

Comparative analysis of SmartArc-based dual arc volumetric-modulated arc radiotherapy (VMAT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma.

Lee TF, Chao PJ, Ting HM, Lo SH, Wang YW, Tuan CC, Fang FM, Su TJ.

J Appl Clin Med Phys. 2011 Nov 15;12(4):3587. doi: 10.1120/jacmp.v12i4.3587.

PMID:
22089015
[PubMed - indexed for MEDLINE]
20.

Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.

Ahmed M, Hansen VN, Harrington KJ, Nutting CM.

Med Dosim. 2009 Fall;34(3):217-24. doi: 10.1016/j.meddos.2008.08.008. Epub 2008 Oct 1.

PMID:
19647632
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk